China NMPA Product Recall - Integrated membrane oxygenator

Medtronic Inc. initiated a voluntary global recall of its integrated membrane oxygenators, as detailed in a National Medical Products Administration (NMPA) report published on December 5, 2016. The recall, reported by Medtronic (Shanghai) Management Co., Ltd. on November 15, 2016, addressed a quality concern involving contaminants, specifically burrs, identified within the plastic material of the oxygenator's arterial sampling port. Although the full potential impact of these burrs had not been conclusively determined, Medtronic proceeded with the recall as a precautionary measure to uphold patient safety standards. These oxygenators are critical for extracorporeal circulation during cardiopulmonary bypass surgery, facilitating blood oxygenation. The recall primarily impacted markets in the USA, Canada, Germany, Greece, and the UK. Notably, Medtronic confirmed that no affected products were sold or imported into the Chinese market. Therefore, no direct corrective actions, such as product returns or modifications, were required from Chinese medical facilities. Under its regulatory framework, the NMPA directed provincial and municipal food and drug administrations to strengthen their supervision over this type of medical product. This emphasizes a commitment to maintaining high standards of medical device safety and quality across the supply chain.